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post PCI angina and chest pain were conducted using Payment by
Results coding in the HES data set. Cost estimates were presented in
2013/14 prices based on the Hospital and Community Health Services
index (HCHS).
RESULTS 32,492 met study inclusion criteria (mean age 64 years
[SD 11.8], 74% male). The cumulative incidence of angina/chest pain
was 23% (n¼ 7,473) at 12 months, 31% (n¼ 10,199) at 24 months and
37% (n¼ 11,940) at 36 months following PCI. It is estimated that
bootstrapped cumulative mean costs to the secondary care provider
were signiﬁcantly higher at 12 months in those with angina/chest
pain at £ 10,215, 95% CI [£10,083, £10,348] vs. £6,552, 95% CI
[£6,503, £6,601] for those without. Signiﬁcant cost differences per-
sisted to 36 months post PCI £ 14,754 95% CI [£14,571 £14,936] for
those with angina vs. £ 8,407, 95% CI [£8,324, £8,489] for those
without.
CONCLUSIONS Our analysis, using real-world data, suggests that
angina and chest pain are common following PCI. Moreover, incidence
increased over time, to the extent that at 36 months over a third of
patients experienced angina/chest pain. This is important because
angina and chest pain have a detrimental impact on patients health
related quality of life. In addition our analysis indicates that resource
consumption is considerably greater in those affected. As angina/
chest pain following PCI are associated with a human and economic
burden, therapeutic strategies, or interventions resulting in a lower
incidence of angina and chest pain post PCI, would have the potential
to reduce the ﬁnancial burden on the NHS.
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BACKGROUND Long-term health-related-quality-of-life (HRQoL)
beneﬁts of percutaneous coronary intervention (PCI) for chronic total
occlusions (CTO) are not well established.
METHODS Consecutive patients undergoing PCI at our institution
from September 2009 to January 2011 were evaluated. EuroQoL-5D
(EQ-5D) health survey was used to assess HRQoL at baseline, 6- 12-, 24
and 36-months. Utility score improvement of 0.11 was considered
minimal clinically important difference (MCID). Changes in quality-
adjusted-life-years (QALY) were compared between patients who
underwent successful single-vessel CTO (S-CTO) with failed CTO (F-
CTO) and successful non-CTO lesion.
RESULTS Of 453 patients who underwent single-vessel PCI, 10.6%
(n¼48) were CTO and 89.4% (n¼405) were non-CTO lesions. PCI was
successful in 72.9% (n¼35/48) CTOs and 98.8% (n¼400/405) non-CTO.
Mean utility scores improved after S-CTO from 0.670.20 to
0.850.16 at 36-months, 0.560.23 to 0.850.16 after S-NCTO and
0.690.17 to 0.890.12 after F-CTO (all p<0.01). 3-year QALY gained
was highest after S-NCTO (0.820.79) compared to S-CTO (0.530.75)
and F-CTO (0.470.76, p<0.01). Baseline utility score was inversely
proportional to QALY gained after S-CTO where the lowest baseline
utility score quartile (<0.47) had the largest QALY gain (1.69)
compared to the highest quartile (>0.71) with the smallest gain (0.16,
p<0.01). Proportion of patients who experienced MCID improvement
at 36-months was lower after S-CTO (64.0%) compared with S-NCTO
(82.6%).
CONCLUSIONS Successful CTO PCI was associated with modest long-
term HRQoL improvement which was signiﬁcantly less than after non-
CTO intervention. About forty percent of patients did not achieve
minimal clinically important improvement in HRQoL 36-month after
successful CTO PCI. High baseline health status was associated with
minimal QALY gain after CTO intervention. Further studies are war-
ranted to identify which CTO patients are most likely to beneﬁt after
PCI.
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BACKGROUND Several clinical and pathological studies have sug-
gested an association between incomplete stent apposition (ISA) and
delayed neointimal healing and adverse events (stent thrombo-
sis).The aim of this study was to evaluate the impact of strut appo-
sition and stent design on progression of stent strut neointimal
coverage.
METHODS To evaluate the impact of ISA on the progression of neo-
intimal coverage, we developed an in-vivo model of ISA and studied
follow-up response and coverage characteristics of well-apposed and
malapposed segments for a series of Drug Eluting Stents (DES)
(Cypher, PROMUS Element and Orsiro) and Bioresorbable Vascular
Scaffolds (ABSORB BVS). Optical Coherence Tomography (OCT) was
sequentially performed at baseline, 1 week and 4 weeks of follow-up.
In addition, evidences were provided by histological analysis per-
formed at 4 weeks follow-up and Computer Fluid Dynamic (CFD)
simulations describing the shear stress characteristics around apposed
versus non-apposed struts.
RESULTS A total of 325 cross sections and 3166 struts were analyzed.
After implantation, stents had an average of 16.1% of struts that were
malapposed or non-apposed side branch (NASB). Malapposition extent
decreased over time as a result of neointimal healing (from 10.9% at
baseline to 0% at 4 weeks; p ¼ 0.03). At 1 week, 8.5% of struts in well
apposed segments were still uncovered versus 14.5% of struts in mal-
apposed cross-sections and 66.7% of NASB struts (p < 0.0001). At 4
weeks follow up, 0% of struts were uncovered in well apposed cross-
sections vs. 0.4% inmalapposed cross-sections and 50% of NASB struts
(p< 0.0001). Comparison of the impact of stent design onwell-apposed
segments revealed that thin strut Orsiro had only 1.1% of uncovered
struts at 1 week while Promus Element, Cypher and BVS had 7%, 48.4%
and 18.2% of struts still uncovered respectively (p < 0.0001).
CONCLUSIONS This study shows that early coverage is inﬂuenced by
stent apposition as well as platform strut characteristics. At 4 weeks,
only NASB struts remained a focus of delayed re-endothelialization.
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